Concordance of mini-mental state examination, Montreal cognitive assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease

Cognitive impairment (CI) is frequently observed in Parkinson’s disease (PD) and negatively influences the patient’s and carer’s quality of life. As a first step, assessment of CI is often accomplished by using screening instruments (level I diagnosis). Three commonly used instruments are the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Parkinson Neuropsychometric Dementia Assessment (PANDA). Because different preferences regarding test selection exist between clinics, this study aims to provide evidence about the concordance of these tests.

Source link

Related posts

Left atrial diameter and vascular brain injury on MRI: The Cardiovascular Health Study


Left hemispatial neglect with a splenial lesion


Are Near Death Experiences Hallucinations?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy